title: Fluorescein angiography of aggressive posterior retinopathy of prematurity treated with intravitreal anti-VEGF in large preterm babies.
authors.affiliation: Department of Ophthalmology, Chonnam National University Medical School and Hospital, Gwangju, Korea.
authors.forename: Sang Woo
authors.initials: SW
authors.lastname: Park
authors.forename: Hyun Ho
authors.initials: HH
authors.lastname: Jung
authors.forename: Hwan
authors.initials: H
authors.lastname: Heo
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D000068258:Bevacizumab; D005451:Fluorescein Angiography; D005865:Gestational Age; D006801:Humans; D007230:Infant, Low Birth Weight; D007231:Infant, Newborn; D007234:Infant, Premature; D058449:Intravitreal Injections; D008297:Male; D047928:Premature Birth; D000069579:Ranibizumab; D015861:Retinal Neovascularization / Q000175:diagnosis / Q000188:drug therapy; D012178:Retinopathy of Prematurity / Q000175:diagnosis* / Q000188:drug therapy*; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab; D000069579:Ranibizumab